Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Sci Rep ; 4: 4702, 2014 Apr 16.
Article in English | MEDLINE | ID: mdl-24736451

ABSTRACT

We fabricated and characterized the material with Mn (10 at.%: atomic percent) doped In3Sb1Te2 (MIST) using co-sputtering and synchrotron radiation, respectively. The MIST thin film showed phase-changes at 97 and 320 °C, with sheet resistances of ~10 kΩ(sq) (amorphous), ~0.2 kΩ(sq) (first phase-change), and ~10 Ω(sq) (second phase-change). MIST did not exhibit any chemical separation or increased structural instability during either phase-change, as determined with high-resolution x-ray photoelectron spectroscopy. Chemical state changes were only depended for In without concomitant changes of Sb and Te. Apparently, doped Mn atoms can be induced with movement of only In atoms.

2.
Br J Anaesth ; 111(3): 368-73, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23533256

ABSTRACT

BACKGROUND: Positive end-expiratory pressure (PEEP) has been known to adversely influence cardiac output. Even though left ventricular (LV) diastolic function significantly contributes to LV performance, the effects of PEEP on LV diastolic function remains controversial. We, therefore, aimed to examine the effects of PEEP on LV diastolic function by use of pulsed wave Doppler tissue imaging in patients with pre-existing LV relaxation abnormality. METHODS: Seventeen patients with peak early diastolic velocity of lateral mitral annulus (E') <8.5 cm s(-1) among patients who underwent coronary artery bypass graft surgery were evaluated. Echocardiographic and haemodynamic variables were measured with 0, 5, and 10 cmH2O of PEEP. E' and deceleration time (DT) of peak early transmitral filling velocity (E) were used as echocardiographic indicators of LV diastolic function. RESULTS: Mean arterial blood pressure decreased during 10 cmH2O PEEP, compared with that during 0 cmH2O PEEP. E' showed a gradual and significant decrease with an incremental increase in PEEP (6.9 ± 0.9, 5.8 ± 0.9, and 5.2 ± 1.2 cm s(-1) during 0, 5, and 10 cmH2O PEEP, respectively), and DT of E was prolonged during 10 cmH2O PEEP, compared with that during 0 cmH2O PEEP. CONCLUSIONS: Increasing PEEP led to a progressive decline in LV relaxation in patients with pre-existing LV relaxation abnormality.


Subject(s)
Positive-Pressure Respiration/adverse effects , Ventricular Dysfunction, Left/diagnostic imaging , Aged , Analysis of Variance , Arterial Pressure , Diastole , Echocardiography, Doppler, Pulsed/methods , Female , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Humans , Male , Ventricular Dysfunction, Left/etiology
5.
J Int Med Res ; 39(1): 96-104, 2011.
Article in English | MEDLINE | ID: mdl-21672312

ABSTRACT

Use of intra-operative trans-oesophageal echocardiography (TEE) is an independent risk factor for post-operative dysphagia. This study investigated whether modifying the TEE probe-placement protocol could reduce the incidence of post-operative dysphagia. In group I (n = 100), the TEE probe was inserted after anaesthetic induction and remained in place until the completion of surgery. In group II (n = 100), the TEE probe was inserted after anaesthetic induction, the heart was examined, then the probe was removed. The probe was inserted again before weaning from cardiopulmonary bypass and then immediately removed after examination. The incidence of dysphagia was significantly higher in group I than in group II patients (51.1% versus 28.6%). Multivariate regression analysis showed that the length of time that the TEE probe was in the oesophagus was an independent predictor of dysphagia. Modification of the TEE protocol in this way can reduce the incidence of post-operative dysphagia in cardiac surgery patients.


Subject(s)
Deglutition Disorders/etiology , Echocardiography, Transesophageal/adverse effects , Esophagus/physiopathology , Aged , Anesthesia/methods , Cardiac Surgical Procedures/adverse effects , Deglutition Disorders/epidemiology , Deglutition Disorders/physiopathology , Echocardiography, Transesophageal/methods , Female , Humans , Incidence , Male , Middle Aged , Multivariate Analysis , Postoperative Period , Prospective Studies , Republic of Korea , Time Factors
6.
Br J Anaesth ; 106(4): 487-93, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21343159

ABSTRACT

BACKGROUND: Lidocaine has been demonstrated to exert cardioprotective effects against myocardial ischaemia and reperfusion injury. We evaluated whether a continuous i.v. infusion of lidocaine reduced myocardial injury in patients undergoing off-pump coronary artery bypass graft surgery (OPCAB). METHODS: In this randomized, double-blinded trial, 99 patients received i.v. lidocaine 2% (i.e. a 1.5 mg kg(-1) bolus at induction of anaesthesia followed by a 2.0 mg kg(-1) h(-1) infusion intraoperatively) or an equal volume of saline. Serum creatine kinase-myocardial band (CK-MB) and troponin I (TnI) concentrations were measured before surgery, upon arrival in the intensive care unit, and at 6, 24, 48, and 72 h after surgery. Cardiac enzymes, other biological markers, and rate of postoperative adverse events were compared between the groups. RESULTS: The median (25-75% inter-quartile range) TnI [0.90 (0.43-1.81) vs 1.71 (0.88-3.02) ng ml(-1), P=0.027] and CK-MB [6.5 (3.9-12.3) vs 9.8 (6.0-18.6) ng ml(-1), P=0.005] concentrations 24 h after surgery were significantly lower in the lidocaine group than in the control group. Moreover, lidocaine infusion reduced the total area under the curve of TnI and CK-MB release after surgery by 42% and 27%, respectively, compared with control. CONCLUSIONS: Continuous i.v. infusion of lidocaine during surgery reduces myocardial injury in patients undergoing OPCAB.


Subject(s)
Anesthetics, Local/therapeutic use , Cardiotonic Agents/therapeutic use , Coronary Artery Bypass, Off-Pump/adverse effects , Lidocaine/therapeutic use , Myocardial Reperfusion Injury/prevention & control , Aged , Biomarkers/blood , Cardiotonic Agents/administration & dosage , Creatine Kinase, MB Form/blood , Double-Blind Method , Female , Humans , Infusions, Intravenous , Lidocaine/administration & dosage , Male , Middle Aged , Myocardial Reperfusion Injury/enzymology , Myocardial Reperfusion Injury/etiology , Troponin I/blood
7.
Acta Anaesthesiol Scand ; 54(8): 962-9, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20626355

ABSTRACT

BACKGROUND: The aim of this study was to evaluate the efficacy of ondansetron and ramosetron in the reduction of post-operative nausea and vomiting (PONV) associated with patient-controlled analgesia (PCA) after cardiac surgery. METHODS: A total of 320 patients scheduled for elective cardiac surgery were enrolled. Patients were randomly assigned to one of four treatment regimens (n=80 in each group): no prophylactic antiemetics (group P); intravenous (i.v.) ondansetron 4 mg at the end of surgery and 12 mg added to PCA (group O); i.v. ramosetron 0.3 mg at the end of surgery and no antiemetics added to PCA (group R1); and i.v. ramosetron 0.3 mg at the end of surgery and 0.6 mg added to PCA (group R2). RESULTS: The incidence of PONV during the 48-h post-operative period was lower in groups O (46%), R1 (54%), and R2 (35%) compared with group P (71%, P<0.001). The incidence and severity of nausea were lower in groups O, R1, and R2 than in group P during the 24-h post-operative period, whereas the incidence and severity of nausea during 24-48 h after surgery were lower in groups O and R2, but not in group R1, than in group P. Compared with group P (53%), the frequency of rescue antiemetic usage was significantly lower in groups O (34%) and R2 (29%), but not in group R1 (43%). CONCLUSION: The addition of either ondansetron or ramosetron to PCA can reduce the incidence of PONV during 48 h after cardiac surgery.


Subject(s)
Antiemetics/therapeutic use , Benzimidazoles/therapeutic use , Cardiac Surgical Procedures , Ondansetron/therapeutic use , Postoperative Nausea and Vomiting/prevention & control , Aged , Analgesia, Patient-Controlled , Anesthesia , Antiemetics/administration & dosage , Benzimidazoles/administration & dosage , Double-Blind Method , Female , Humans , Infusions, Intravenous , Injections, Intravenous , Male , Middle Aged , Ondansetron/administration & dosage , Pain, Postoperative/epidemiology , Postoperative Care , Postoperative Nausea and Vomiting/diagnosis
8.
Transplant Proc ; 41(5): 1979-81, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19545773

ABSTRACT

Aggravation of mitral regurgitation (MR) due to left ventricular outflow tract obstruction (LVOTO) is likely to occur during liver transplantation in cirrhotic patients with hypertrophic cardiomyopathy (HCMP). Moreover, calcium administration following severe hypocalcemia due to inadequate citrate metabolism and massive transfusion may induce MR aggravation with LVOTO in such patients. Herein we have described a cirrhotic patient with HCMP in whom MR was aggravated due to LVOTO resulting from inadvertent rapid administration of calcium during liver transplantation.


Subject(s)
Calcium Chloride/adverse effects , Cardiomyopathy, Hypertrophic/complications , Intraoperative Complications/chemically induced , Liver Transplantation/methods , Mitral Valve Insufficiency/chemically induced , Ventricular Outflow Obstruction/chemically induced , Echocardiography, Transesophageal , Female , Hemodynamics/drug effects , Hemodynamics/physiology , Humans , Hypocalcemia/drug therapy , Hypocalcemia/etiology , Middle Aged , Treatment Outcome
9.
Clin Exp Dermatol ; 34(3): 352-4, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19175787

ABSTRACT

We report the case of a 69-year-old man with a history of multiple erythematous bullae on both forearms, which had been present for about 1 month. The lesions appeared after several years of topical corticosteroid application and photoageing. A biopsy revealed lymphangiectasia with solar elastosis and increase in the ratio of elastic to collagen fibres in the dermis. We suggest that this patient's lymphangiectasia resulted from abnormal structure and function of the dermis due to photoageing and steroid-related atrophy.


Subject(s)
Drug Eruptions/etiology , Glucocorticoids/adverse effects , Lymphangiectasis/etiology , Skin Aging/pathology , Administration, Cutaneous , Aged , Arm/pathology , Drug Eruptions/pathology , Humans , Lymphangiectasis/chemically induced , Lymphangiectasis/pathology , Male
10.
Int J Clin Pharmacol Ther ; 45(12): 654-8, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18184533

ABSTRACT

OBJECTIVE: The aims of this study were to evaluate the use of antimicrobial agents in the fever wards of a Hong Kong teaching hospital and to identify those factors associated with treatment failure and having an influence on the total direct medical costs of antimicrobial therapy. METHODS: This was a retrospective observational study. Demographic and clinical data were collected on 123 patients admitted to the fever wards in a local teaching hospital between July 2004 and August 2004. Multivariate analyses were performed to identify factors associated with treatment failure and the total direct medical treatment cost. RESULTS: The rate of treatment failure was 30.1% (37 out of 123 patients). The mean total direct medical cost was HK$ 26,442 +/- 17,153 (US$ 1 = HK$ 7.8). The empirical therapy in 90 (73.2%) patients complied with the institutional guidelines. 25 (20.3%) patients were eligible for renal dosage adjustment and in 7 (28%) of these patients the dosage of antimicrobial agents was renally adjusted. Of the 27 patients in whom pathogens were identified, 9 (33.3%) patients were eligible for antimicrobial streamlining (changing to an antibiotic with a narrower spectrum) but streamlining was only done in 2 (22.2%) patients. Multivariate analysis showed that the history of malignant diseases (RR = 5.07; 95% CI = 1.06 - 24.22) and non-compliance with the institutional treatment guidelines for selection of empirical antimicrobial therapy (RR = 3.58; 95% CI = 1.35 - 9.54) were risk factors associated with treatment failure. Duration of intravenous antimicrobial therapy was associated with the total cost of treatment (RR = 1.60; 95% CI = 1.35 - 2.10). CONCLUSION: Non-compliance with treatment guidelines in empirical antimicrobial treatment and the duration of intravenous antimicrobial therapy were modifiable risk factors for treatment failure and total treatment cost, respectively.


Subject(s)
Anti-Infective Agents/economics , Anti-Infective Agents/therapeutic use , Communicable Diseases/drug therapy , Communicable Diseases/economics , Hospitals, Teaching/economics , Aged , Aged, 80 and over , Female , Fever , Guideline Adherence , Health Care Costs , Hong Kong , Humans , Male , Middle Aged , Practice Guidelines as Topic , Treatment Failure
11.
Br J Dermatol ; 154(5): 829-38, 2006 May.
Article in English | MEDLINE | ID: mdl-16634882

ABSTRACT

BACKGROUND: Radiation induces many cellular events leading to radiodermatitis. OBJECTIVES: The aim of this study was to establish a radiodermatitis model using experimental animals, and to examine the expression profile of radiation-induced genes. METHODS: Hairless mice were irradiated on the dorsal skin; then total RNAs were isolated and microarray hybridizations were performed. RESULTS: Irradiation with a total of 40 Gy (10 Gy day-1 for four consecutive days) provokes radiodermatitis in the hairless mouse. After microarray analysis, 130 genes that showed upregulation by radiation were selected and organized into four different clusters, depending on the time-kinetic pattern. Classification of these genes into several functional categories revealed that various biological processes were globally affected by radiation. These include transcription regulation, signal transduction, cell communication, cell death regulation and metabolism. CONCLUSIONS: These results demonstrate the complexity of the transcriptional profile of the radiation response, providing important clues on which to base further investigations of the molecular events underlying radiodermatitis.


Subject(s)
Disease Models, Animal , Radiodermatitis/genetics , Animals , Dose-Response Relationship, Radiation , Gene Expression Profiling , Male , Mice , Mice, Hairless , Microarray Analysis , Multigene Family , Polymerase Chain Reaction/methods , Radiodermatitis/etiology , Up-Regulation/radiation effects , Weight Loss/radiation effects
12.
Ann N Y Acad Sci ; 991: 272-7, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12846993

ABSTRACT

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Recent observations link cyclooxygenase type-2 (COX-2) to the progression of the disease. Consistent with this notion, studies with the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) show that inhibition and ablation of COX-2 markedly reduce the deleterious effects of this toxin on the nigrostriatal pathway. The similarity between this experimental model and PD strongly supports the possibility that COX-2 expression is also pathogenic in PD.


Subject(s)
Isoenzymes/metabolism , Nerve Degeneration/etiology , Parkinson Disease/physiopathology , Prostaglandin-Endoperoxide Synthases/metabolism , Animals , Anti-Inflammatory Agents/therapeutic use , Cyclooxygenase 2 , Humans , MPTP Poisoning/drug therapy , MPTP Poisoning/metabolism , MPTP Poisoning/physiopathology , Meloxicam , Membrane Proteins , Mice , Parkinson Disease/enzymology , Substantia Nigra/injuries , Substantia Nigra/physiopathology , Thiazines/therapeutic use , Thiazoles/therapeutic use
13.
Brain Res ; 909(1-2): 8-19, 2001 Aug 03.
Article in English | MEDLINE | ID: mdl-11478917

ABSTRACT

The exposure of humans and experimental animals to certain industrial toxins such as acrylamide is known to cause nerve damage classified as axonopathy, but the mechanisms involved are poorly understood. Here we show that acrylamide induces morphological changes and tyrosine phosphorylation of focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2), a member of the FAK subfamily, in human differentiating neuroblastoma SH-SY5Y cells. Furthermore, we identified a novel molecule designated 'compound-1' that inhibits the morphological and biochemical events. Daily oral administrations of the compound also effectively alleviated behavioral deficits in animals elicited by acrylamide in inclined plane testing, landing foot spread testing and rota-rod performance testing. The compound also effectively inhibited the biological and biochemical responses caused by another axonopathy inducer, colchicine, including tyrosine phosphorylation of Pyk2, formation of an 85-kDa poly(ADP-ribose)polymerase (PARP) fragment and apoptosis-associated induction of the NAPOR gene as well as neuronal cell death. Our findings not only provide insight into FAK and Pyk2 functions in neuronal cells, but may also be important in the development of therapeutic agents for peripheral neuropathy and neurodegeneration.


Subject(s)
Acrylamides/toxicity , Apoptosis/drug effects , Axons/drug effects , Benzimidazoles/pharmacology , Colchicine/toxicity , Cyclopentanes/pharmacology , Imidazoles/pharmacology , Nerve Degeneration/drug therapy , Neuroprotective Agents/pharmacology , Apoptosis/physiology , Axons/metabolism , Axons/pathology , CELF Proteins , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Focal Adhesion Kinase 1 , Focal Adhesion Kinase 2 , Focal Adhesion Protein-Tyrosine Kinases , Humans , Imidazoles/chemistry , Movement Disorders/drug therapy , Movement Disorders/etiology , Movement Disorders/physiopathology , Nerve Degeneration/chemically induced , Nerve Degeneration/physiopathology , Nerve Tissue Proteins , Peripheral Nervous System Diseases/chemically induced , Peripheral Nervous System Diseases/drug therapy , Peripheral Nervous System Diseases/physiopathology , Phosphorylation/drug effects , Poly(ADP-ribose) Polymerases/drug effects , Poly(ADP-ribose) Polymerases/metabolism , Protein-Tyrosine Kinases/drug effects , Protein-Tyrosine Kinases/metabolism , RNA, Messenger/drug effects , RNA, Messenger/metabolism , RNA-Binding Proteins/genetics , Signal Transduction/drug effects , Signal Transduction/physiology , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism , Tumor Cells, Cultured/pathology
14.
Curr Opin Neurol ; 14(4): 483-9, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11470965

ABSTRACT

Parkinson's disease is a common neurodegenerative disorder characterized by the progressive loss of the dopaminergic neurons in the substantia nigra pars compacta. The loss of these neurons is associated with a glial response composed mainly of activated microglial cells and, to a lesser extent, of reactive astrocytes. This glial response may be the source of trophic factors and can protect against reactive oxygen species and glutamate. Aside from these beneficial effects, the glial response can mediate a variety of deleterious events related to the production of reactive species, and pro-inflammatory prostaglandin and cytokines. This article reviews the potential protective and deleterious effects of glial cells in the substantia nigra pars compacta of Parkinson's disease.


Subject(s)
Astrocytes/physiology , Microglia/physiology , Parkinson Disease/physiopathology , Chemokines/metabolism , Cytokines/metabolism , Dopamine/physiology , Humans , Neurons/physiology , Substantia Nigra/physiopathology
15.
Mamm Genome ; 12(5): 347-51, 2001 May.
Article in English | MEDLINE | ID: mdl-11331941

ABSTRACT

For understanding the pathogenesis of Down syndrome (DS), it is important to identify and characterize the genes on Chromosome (Chr) 21, especially those in the Down syndrome critical region (DSCR) on Chr 21q22.2. Recently we have determined 33.5 Mb (more than 99%) of DNA sequence of Chr 21 and, from these sequence data, we identified a novel gene, DSCR5 (transcript = 0.8 kb), from DSCR by combination of computational gene prediction and cDNA screening. For functional analysis of DSCR5, we identified a mouse homolog of the DSCR5 cDNA, and termed it mDscr5 (transcript length = 0.8 kb). The gene was mapped to mouse Chr 16 C3-C4, the syntenic region of human Chr 21, and encodes an amino acid of 132 residues with 90% identity to DSCR5. In situ hybridization showed that mDscr5 is predominantly expressed in the developing tongue. To our best knowledge, no other gene in DSCR is reported to be expressed in tongue, so that DSCR5 may be the first candidate to elucidate the pathophysiology of tongue malformation observed in DS.


Subject(s)
Down Syndrome/genetics , Membrane Proteins , Proteins/genetics , Tongue/embryology , Tongue/metabolism , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cell Line , Chromosomes, Human, Pair 21/genetics , Cloning, Molecular , Expressed Sequence Tags , Gene Expression Regulation, Developmental , Hexosyltransferases , Humans , In Situ Hybridization, Fluorescence , Mice , Microscopy, Fluorescence , Molecular Sequence Data , Organ Specificity , Physical Chromosome Mapping , Protein Transport , Proteins/analysis , Proteins/chemistry , RNA, Messenger/analysis , RNA, Messenger/genetics , Rats , Sequence Alignment , Sequence Homology , Transfection
16.
DNA Res ; 7(3): 207-12, 2000 Jun 30.
Article in English | MEDLINE | ID: mdl-10907851

ABSTRACT

Based on a detailed sequence of the distal Down syndrome critical region (DSCR), we predicted and molecularly cloned a novel gene, designated DSCR5. We determined the sequences of expressed sequence tags (ESTs) that almost matched the predicted cDNA sequence of DSCR5. Northern blot analysis showed that DSCR5 is expressed in several tissues including the liver, skeletal muscle, heart, pancreas and testis. To determine the 5'-end of DSCR5, the oligo-capping method was employed. Combining the EST sequence data and that from the oligo-capping experiments, we obtained the full-length cDNA sequence of DSCR5. DSCR5 had at least four types of alternatively spliced variants. According to the number of exons, they could be classified into two subtypes: DSCR5alpha and DSCR5beta. DSCR5alpha includes three splice variant subtypes, DSCR5alpha1, alpha2 and alpha3, which each has different first non-coding exon. In addition, the most abundantly isolated form, DSCR5alpha1, shows microheterogeneity of the mRNA start site. Comparison of the sequences between the predicted cDNA and the molecularly cloned cDNA revealed that the computer programs had limited validity to correctly predict the terminal exons. Thus, molecular cloning should always be required to complement the inadequacy of the computer predictions.


Subject(s)
Chromosomes, Human, Pair 21 , Down Syndrome/genetics , Membrane Proteins , Proteins/genetics , Alternative Splicing , Amino Acid Sequence , Base Sequence , Blotting, Northern , Cloning, Molecular , Computer Simulation , DNA, Complementary/metabolism , Exons , Expressed Sequence Tags , Hexosyltransferases , Humans , Models, Genetic , Molecular Sequence Data , RNA, Messenger/metabolism , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid , Tissue Distribution , Tumor Cells, Cultured
17.
Nature ; 405(6784): 311-9, 2000 May 18.
Article in English | MEDLINE | ID: mdl-10830953

ABSTRACT

Chromosome 21 is the smallest human autosome. An extra copy of chromosome 21 causes Down syndrome, the most frequent genetic cause of significant mental retardation, which affects up to 1 in 700 live births. Several anonymous loci for monogenic disorders and predispositions for common complex disorders have also been mapped to this chromosome, and loss of heterozygosity has been observed in regions associated with solid tumours. Here we report the sequence and gene catalogue of the long arm of chromosome 21. We have sequenced 33,546,361 base pairs (bp) of DNA with very high accuracy, the largest contig being 25,491,867 bp. Only three small clone gaps and seven sequencing gaps remain, comprising about 100 kilobases. Thus, we achieved 99.7% coverage of 21q. We also sequenced 281,116 bp from the short arm. The structural features identified include duplications that are probably involved in chromosomal abnormalities and repeat structures in the telomeric and pericentromeric regions. Analysis of the chromosome revealed 127 known genes, 98 predicted genes and 59 pseudogenes.


Subject(s)
Chromosomes, Human, Pair 21 , Base Sequence , Chromosome Mapping , DNA , Down Syndrome/genetics , Genes , Humans , Molecular Sequence Data , Mutation , Sequence Analysis, DNA
18.
J Biol Chem ; 275(37): 28739-49, 2000 Sep 15.
Article in English | MEDLINE | ID: mdl-10852903

ABSTRACT

The rise in cytosolic Ca(2+) concentration (Ca(2+)(i)) in vascular endothelial cells (ECs) activates the production and release of nitric oxide (NO). NO modifies Ca(2+)(i) homeostasis in many types of nonendothelial cells. However, its effect on endothelial Ca(2+)(i) homeostasis at basal and excited states remains unclear. In the present study, to elucidate the effect of NO on basal Ca(2+)(i), inositol 1,4,5-trisphosphate-induced Ca(2+)(i) release (IICR) was blocked by expressing an antisense against type-1 inositol 1,4,5-trisphosphate receptors or by microinjecting heparin to individual ECs, and the effects of NO that was released by and diffused from adjacent IICR-intact ECs were recorded. After ATP or bradykinin stimulation, IICR-inhibited ECs showed a marked reduction of basal Ca(2+)(i), which was abolished by N(G)-monomethyl-l-arginine monoacetate pretreatment. The reduction disappeared in sparsely seeded ECs. Exogenous NO gas mimicked the effect of ATP or bradykinin to reduce basal Ca(2+)(i). Blocking plasma membrane Ca(2+)-ATPase (PMCA), but not Na(+)-Ca(2+) exchange or sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase, suppressed the reduction, indicating that the reduction resulted from a NO-dependent potentiation of PMCA. To elucidate the effect of NO on elevated Ca(2+)(i), ATP-, bradykinin-, or thapsigargin-evoked Ca(2+)(i) response in the presence and absence of NO production was compared in adjacent IICR-intact ECs. NO was found to potentiate PMCA, which, in turn, greatly attenuated agonist-evoked Ca(2+)(i) elevation. NO also potentiated Ca(2+) influx, which markedly increased the sustained phase of Ca(2+)(i) elevation and possibly NO production. NO did not affect other Ca(2+)(i)-elevating and Ca(2+)(i)-sequestrating components. Thus, NO-dependent potentiation of PMCA is crucial for Ca(2+)(i) homeostasis over a wide Ca(2+)(i) range.


Subject(s)
Calcium/metabolism , Endothelium, Vascular/metabolism , Homeostasis , Nitric Oxide/physiology , Adenosine Triphosphate/pharmacology , Amino Acid Sequence , Animals , Bradykinin/pharmacology , Calcium-Transporting ATPases/physiology , Cattle , Cells, Cultured , Endothelium, Vascular/cytology , Heparin/pharmacology , Inositol 1,4,5-Trisphosphate/physiology , Molecular Sequence Data , Transfection , omega-N-Methylarginine/pharmacology
19.
Gene ; 237(1): 135-42, 1999 Sep 03.
Article in English | MEDLINE | ID: mdl-10524244

ABSTRACT

Proteins with RNA recognition motifs (RRMs) participate in many aspects of RNA metabolism, and some of them are required for the accomplishment of normal development. The neuroblastoma apoptosis-related RNA binding protein (NAPOR) is an ELAV-type RNA-binding protein with three characteristic RNP2/RNP1-type RRMs, which we identified as a gene induced during apoptosis of neuroblastoma cells. Here we isolated and characterized the cDNA for mNapor, the mouse homolog of NAPOR. The mNapor encodes mRNA sharing striking homology with that of NAPOR, not only in its open reading frame (98.5%) but also in the 3'-untranslated region (80.1%), and is mapped to chromosome 2 A2-A3, a region syntenic to the human NAPOR locus. In situ hybridization analysis revealed that the expression pattern of mNapor is spatially and temporally coincident with the occurrence of programmed cell death, suggesting its involvement in the development of the central nervous system in which apoptosis plays a crucial role.


Subject(s)
Chromosome Mapping , Gene Expression Regulation, Developmental , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Amino Acid Motifs , Amino Acid Sequence , Animals , Apoptosis/genetics , Base Sequence , CELF Proteins , Cerebral Cortex/embryology , Cerebral Cortex/growth & development , Cloning, Molecular , DNA, Complementary , Humans , Mice , Molecular Sequence Data , Nerve Tissue Proteins , Organ Specificity , Spinal Cord/embryology , Spinal Cord/growth & development
20.
Gene ; 223(1-2): 21-31, 1998 Nov 26.
Article in English | MEDLINE | ID: mdl-9858671

ABSTRACT

Identification of differentially expressed genes will provide leads in the elucidation of the molecular mechanisms underlying neuronal cell death associated with neurodegenerative disorders. Using a high-throughput fluorescent differential display (FDD) system based on an automated DNA sequencer, we analyzed global patterns of gene expression during the apoptosis of neuroblastoma SH-SY5Y cells induced by a neurotoxin, colchicine. Initial screening of approximately 24000 cDNA bands displayed with 320 primer combinations has revealed 263 fragments showing differential expression patterns, suggesting that approximately 1% of transcripts are modulated in their expression level. Of these differentially displayed bands, we cloned 18 fragments composed of 17 distinct species and confirmed differential expression of each species by reverse transcription-PCR or Northern blot hybridization, thereby proving the reliability of the approach. These include eight derived from seven known genes, five homologous to expressed sequence tags (ESTs), and five totally lacking any homology to those deposited in the database. Among these, a novel transcript SAI1 induced prominently was characterized further and revealed to encode a putative RNA-binding protein NAPOR (neuroblastoma apoptosis-related RNA-binding protein), containing three copies of evolutionarily conserved RNA recognition motif. Since several RNA-binding proteins have been known to play crucial roles in other apoptosis systems, it is conceivable that NAPOR is also involved in the process of neuronal cell death.


Subject(s)
Gene Expression Regulation, Neoplastic , Genetic Techniques , Neuroblastoma/genetics , Neuroblastoma/pathology , RNA-Binding Proteins/genetics , Amino Acid Sequence , Apoptosis/genetics , Base Sequence , CELF Proteins , Cloning, Molecular , Colchicine/pharmacology , Fluorescence , Humans , Molecular Sequence Data , Nerve Tissue Proteins , Neuroblastoma/drug therapy , RNA-Binding Proteins/drug effects , RNA-Binding Proteins/metabolism , Sequence Homology, Amino Acid , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...